ARTICLE | Clinical News
Cubist reports more Cidecin data
September 24, 2001 7:00 AM UTC
CBST released additional data from a Phase III trial of its Cidecin in patients with complicated skin and soft tissue infection (cSST) caused by Gram-positive pathogens in which the compound improved ...